Viatris Inc. (Nasdaq: VTRS) announced today that Matthew J. Maletta has been appointed Chief Legal Officer (CLO), effective ...

If Justice Breyer, writing for the majority, hoped that deferring the particulars to the lower courts would eventually result in clarity, that hope generally appears to have been unfounded. Instead, ...

(RTTNews) - Actavis Plc. (ACT) announced earnings for third quarter that decreased from the same period last year but beat the Street estimates. The company's bottom line totaled $164.20 million, or ...

Teva’s Actavis division has a new product that has been cleared by the Food and Drug Administration. The FDA has approved Actavis’ pemetrexed, a generic of the branded chemotherapy treatment Alimta in ...

“Reverse-payment settlements implicate crucial issues in the patent-antitrust intersection. In its Impax ruling, the FTC faithfully applied the Supreme Court’s Actavis decision, respecting and ...

What has happened in these five years? For starters, the number of “pay for delay” settlements (involving payment and delayed entry) has declined. It has been five years since FTC v. Actavis. In that ...

Case Name: Recro Gainesville LLC v. Actavis Labs. FL, Inc., Civ. No. 14-1118-GMS, 2017 U.S. Dist. LEXIS 24428 (D. Del. Feb. 22, 2017) (Sleet, J.) Drug Product and U.S ...

The specialty and generic drugmaker gets another boost from its 2016 purchase of Actavis Generics from Allergan. Teva announced its first-quarter 2017 results before the market opened on Thursday. The ...

Actavis faces fines for raising the cost of hydrocortisone tablets by more than 12,000 percent, the U.K. antitrust regulator said Friday as it continued a crackdown on excessive pricing in the drug ...

As a result of Israel-based Teva Pharmaceutical Industries acquisition of Dublin-based Allergan ’s generics business, Actavis Generics, Actavis has announced it will lay off 200 workers by the end of ...

Teva's acquisition of Actavis' generics business made a huge difference in the company's third-quarter results. Were it not for the $887 million in additional revenue resulting from this deal, Teva ...